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Abstract
Breast cancer, with an increasing incidence, is the most frequently diagnosed cancer in women worldwide. The
treatments proposed, generally a combination of surgery, radiotherapy, chemotherapy, endocrine therapy and/or
targeted therapy, are constantly improving, allowing a reduction in the mortality rate, but they are still causing
many side effects, not only early but also late, which leads us to consider the post-cancer period as a chronic
condition. Side effects, reviewed in this commentary, may affect physical functions, psychological status, social
situation, body composition, well-being and quality of life of the patient. In view of the extent of these areas in
which side effects of breast cancer and of its treatments can be found, the supportive care offered at the end of
treatment need to be multidisciplinary. Different supportive care interventions may be proposed to the patients
such as psychological and behavioral interventions, complementary therapies, diet interventions, physical
activity/rehabilitation or also physiotherapy interventions for example, all having shown some beneficial effects
in the literature. The benefits of these supportive care interventions are thereby already established and they are
described in this article, but others studies will be needed to clearly define indications and most optimal modalities
of application to reduce side effects and improve quality of life of patients.
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Background
Because of its incidence, the incurred treatments and es-
pecially its multiple clinical and social consequences,
breast cancer constitutes a real public health issue.
This cancer remains the most frequently diagnosed in
women worldwide with, among others, 1 380 000 new
cases reported in 2008 (23 % of all cancers) and its inci-
dence continues to rise [1, 2].
Different treatments may be proposed, generally a
combination of surgery, radiotherapy, chemotherapy,
endocrine therapy and/or targeted therapy. Their effect-
iveness is constantly increasing, allowing a reduction in
mortality [3, 4]. Thereby, between 1992 and 2002 for ex-
ample, the death rate from breast cancer has decreased
by 13,4 % in Europe for women of all ages and by 16,7 %
for those aged 35 to 64 [5].
However, despite this progress, breast cancer and its
treatments are still causing many psychological, physical,
and social side effects, not only early but also late, which
leads us to consider the post-cancer period as a chronic
condition. In view of the extent of the areas in which
side effects of breast cancer and of its treatments can be
found, the supportive care offered during and at the end
of treatment need to be multidisciplinary.
We will thus, in this paper, review the various treatment-
related side effects and the different supportive care
interventions aiming to improve them.
Main text
Side effects of breast cancer and of its treatments
Surgery
Surgery, including radical mastectomy and lumpectomy,
associated or not with axillary dissection, remains the
centerpiece of breast cancer treatments [6]. Although
the techniques continue to improve, various side effects
can be observed. The most common complication en-
countered directly after breast surgery is wound infec-
tion, with an incidence of 4,34 % 30 days after radical
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mastectomy and 1,97 % after lumpectomy with axillary
dissection [7]. Cardiac and pulmonary complications are
uncommon with a rate of 0,12 % after mastectomy and
0,66 % after lumpectomy and axillary dissection [7].
Similarly, central nervous system complications are rare
with rates of 0,12 and 0,07 % respectively and the urin-
ary tract infection rates are 0,66 and 0,14 %, respectively
[7]. Then, surgery remaining a mutilating action in the
eyes of patients [6], the image of themselves may be im-
paired and particularly after radical mastectomy [8, 9].
Similarly, sexual functioning [8, 9] and role in society [9]
also appear sometimes altered. Finally, surgery is also
found responsible for fatigue and pain [10].
Axillary dissection can cause additional side effects
including lymphedema, numbness, loss of strength and
reduction of arm movement amplitude [8, 10–12] redu-
cing the quality of life [8, 12]. The incidence rate published
for lymphedema varies between 2 % and 65 % depending
on the surgical technique, the axillary sampling method
and the use of chemotherapy and radiotherapy [13].
Radiotherapy
Short-term side effects of radiation therapy are erythema
observed in over 50 % of women [14–16], the dry peel-
ing in 6 to 10 % of cases, or wet in more than 50 % of
cases [10, 14–16], fatigue [10, 15, 16] more or less pro-
nounced depending on the treatment history and
present in over 50 % of women [14], but also edema of
the subcutaneous fat [10, 16], esophagitis following ir-
radiation of the mammary chain [16], hyperpigmentation
[10, 15, 16], myelosuppression [14], pain [10, 15, 17]
as well as anxiety, depression and decreased quality of
life [14].
The long-term effects, however rare, include lymph-
edema of the arm [10, 12, 16] present in 6 to 10 % of pa-
tients after lymph node irradiation [14], subcutaneous
fibrosis with possible telangiectasia [16, 17] in 10 to
50 % of cases [14], the pulmonary disorders including
pneumonia with fever, cough and breathlessness [10, 16]
with an incidence of less than 1 % [14], brachial plexitis
[10, 15–17] as well as heart problems such as arrhyth-
mias, pericarditis, ischemic heart disease and myocardial
infarction [10, 16, 17] again present in less than 1 % of
cases [14].
Chemotherapy
Chemotherapy is an important systemic treatment in the
management of breast cancer. Depending on the drugs
administered to the patient, it can cause various side ef-
fects including asthenia [10, 14, 18–22] which is the
most common. Asthenia is, indeed, encountered in 70 to
100 % of patients during the course of chemotherapy
[21, 23], but also thereafter [18, 19, 21]. The intensity of
fatigue appears stable during treatment [19, 21] and
60 % of patients present a moderate to severe level of
fatigue [23].
Alopecia is another side effect often encountered in
the case of chemotherapy [14, 17, 18, 21, 24] and alter-
ing the self-image of women [22]. Nausea and vomiting
[14, 18, 21, 22, 24], diarrhea [14, 18, 22], leucopenia and
neutropenia within days of each cycle [10, 14, 24, 25],
infection [18, 25] and the appearance of neurological
toxicity with motor and sensory peripheral neuropathies
mainly caused by taxanes [10, 14, 24, 25] are other side ef-
fects experienced by the patients. In addition, weight gain
[10, 14, 18, 21, 24] and ovarian failure resulting in meno-
pausal symptoms including vaginal dryness, hot flashes,
dyspareunia, sleep disorders and/or osteoporosis are other
frequently observed side effects [10, 14, 18, 20, 24, 26].
Similarly, pain [10, 14, 18, 21], heart problems [10, 14],
pulmonary problems [10], cognitive dysfunction with
difficulties in memory, concentration and language
[10, 14, 20, 24], anxiety and finally depression [21, 27]
are other complications of chemotherapy that adversely
affect the quality of life of patients [8, 14, 22, 25, 27].
Endocrine therapy
Like other treatments, endocrine therapy may cause side
effects consisting mainly in menopausal symptoms: vaginal
dryness, hot flashes, dyspareunia, sleep disorders or de-
creased bone density and increased risk of bone fracture
[10, 14, 17, 26]. Endocrine therapy may also cause pain, fa-
tigue, an increase in body weight and vasomotor symptoms
[10, 14]. Other gynecological and sexual problems are also
observed: vaginal discharge, mucosal atrophy, loss of libido
and dyspareunia [10, 28].
Targeted therapy
Finally, targeted therapy or immunotherapy is indicated
in the breast cancer treatment if there is an overexpres-
sion of the HER2 protein (15 to 20 % of cases) and/or an
amplification of the gene [29, 30]. Although the therapy
is thus more selective, it unfortunately also generates
adverse effects. Depending on the drug used, nausea
[31, 32], diarrhea [31, 32], fatigue [32], headache [32],
fever [29, 30, 32], cardiac side effects [29, 30, 32] and
dermatological disorders [31, 32] may appear.
In summary, therapy of breast cancer and outcome is
improving but side effects are still frequent and are best
managed by a multidisciplinary team.
Supportive care
Supportive care aim to improve the quality of life of the
patient by different interventions including symptom
control, psychological and social supports, physical re-
habilitation, educational needs and sometimes the end of
life care, which requires a multidisciplinary cooperation
and coordination [33–35].
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Thus, to meet the patient's needs, we will discuss differ-
ent supportive care interventions that can provide help
and support and which have already been evaluated in
several clinical.
Psychosocial and behavioral interventions
Different systematic reviews and meta-analyses have
already analyzed the benefits provided by psychosocial
and behavioral interventions to patients who have been
treated for breast cancer [36–42]. These interventions
include the terms “individual, group or couple psychother-
apy, psychosocial therapy, psychoeducation, emotional
and social support group, cognitive behavioral therapy,
health education and telephone or oral counseling and
support”. Although they vary in terms of content, dur-
ation, frequency and modality of access for the patient,
these interventions have a positive impact on emotional or
psychological distress [36, 39, 40, 42], anxiety [36, 37, 39],
depression [36, 37, 39, 41], fatigue [37], sleep disorders
[43, 44], body-image [37], stress [37, 39], relationship func-
tioning [40] and on quality of life [36, 37, 39–41].
Complementary therapies
In complementary therapies, we include relaxation,
meditation, yoga, music therapy, stress management
and massage. These interventions may also be recom-
mended as supportive care options during and/or after
breast cancer treatment because they also show positive
effects on anxiety [36–38], depression [36–38], emotional
distress [36], mood disorders [38], stress [37, 38], fatigue
[37, 38], sleep disruption [38, 44] and quality of life
[36, 38]. However, as psychosocial and behavioral inter-
ventions, these interventions should be recommended
based on professional judgment and patient preferences.
Diet intervention
Overweight or obesity at the time of diagnosis is a poor
prognosis factor and may be associated with a variety
of undesirable outcomes such as an increase in the risk
of recurrence and disease-specific or overall mortality
[45–48]. Moreover, weight gain is a common side effect
after chemotherapy [10, 14, 18, 21, 24] and/or endocrine
therapy [10, 14] and it seems to be the result of an in-
crease in adipose tissue mass [45]. To prevent this weight
gain and to improve food choices, the American Cancer
Society wrote a report in which they discuss nutrition
guidelines for cancer survivors [45]. According to this
guideline, breast cancer survivors should try to maintain a
healthy weight by eating a balanced diet and by practicing
regular physical activity. Diets should emphasize vegeta-
bles and fruits, have low amounts of saturated fats and in-
clude sufficient dietary fiber [45, 47]. Furthermore, other
studies show the efficacy of in-person and telephone
counseling/nutrition education in weight loss strategies
and dietary improvement in women treated for breast
cancer [48, 49].
Physical activity/rehabilitation
To prevent weight gain, but also for its many beneficial
effects on psychological and physical aspects, a regular
physical activity is recommended for patients treated for
breast cancer [10, 37, 50, 51]. Inactivity should be
avoided and daily activities should be resumed as soon
as possible after surgery and during adjuvant cancer
treatment [10, 45, 51]. More specifically, concerning
aerobic training, 20 to 60 min of exercise at a moderate
intensity (50–75 % of the maximal heart rate) are rec-
ommended 3 to 5 times per week [10, 45, 51, 52]. For
resistance training, it is recommended to follow a su-
pervised program of approximately 2 to 3 sets of 8 to
15 repetitions with a very low load at baseline, 2 to 3
times a week. The resistance can be increased in small
increments without any upper limit, but it is important
to monitor the appearance of symptoms of the arm
and/or shoulder such as a lymphedema and to reduce
the resistance or stop the exercises according to the
complications observed [10, 45, 52]. Finally, with regard
to stretching, it is advisable to stretch the large muscle
groups for 10 to 30 s 2 to 3 times per week [10, 45].
Many clinical trials and systematic reviews have evalu-
ated the benefits of physical training in patients being
treated for breast cancer. Although these studies differ
according to timing of the intervention (during or after
treatment), location (home or institution), duration, fre-
quency and type of exercises performed and thus although
no consensus is yet clear on these parameters, many bene-
fits have been objectified. Thus, in view of the literature,
physical activity/rehabilitation can have a positive impact
on the quality of life of breast cancer patients [10, 37, 50,
53–65], on fatigue [10, 37, 50, 54, 56, 57, 60, 63, 66–68],
on cardiopulmonary function (resting and/or maximal
heart rate and maximal oxygen consumption) [10, 50, 53,
57, 58, 60, 61, 67–74], on weight and body composition
(body weight, body mass index and/or percentage of body
fat or lean mass) [10, 50, 57, 61, 66, 69, 71, 75–77] and on
the psychological, emotional and physical well-being (such
as anxiety, depression, body-image) [10, 37, 50, 54, 55, 57,
60, 61, 67, 72, 75].
Physiotherapy interventions
Lymphedema is a side effect often encountered as a re-
sult of breast cancer surgery and/or radiotherapy. The
physiotherapist, with a manual lymphatic drainage asso-
ciated with the implementation of compression bandages
and/or compression therapy, skin care and remedial ex-
ercises, may help to reduce swelling, but also pain and
heaviness [12, 78]. Moreover, early physiotherapy inter-
ventions (including manual lymphatic drainage, massage
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of scar tissue, shoulder exercises, and educational
strategy) also seem to be effective in the prevention of
lymphedema [78].
Finally, all these interventions have shown in the lit-
erature the benefits they could bring as supportive care,
but all should not always be prescribed to all patients.
These supportive care modalities should be administered
by qualified and experienced providers which take into
account the risk-benefit ratio for each therapy, the pa-
tients’ clinical characteristics (such as stage of disease,
the overall goal of anticancer therapy, patient perform-
ance status and patient adherence), the communication
with all health-care providers involved in the patient’s
care and also the patient preference [38].
Conclusions
Due to its high incidence and the side effects experienced
as a result of the disease and its treatment, breast cancer
constitutes a real public health problem and can be consid-
ered as a chronic condition. As side effects affect physical
functions and the psychological status, social situation,
body composition and well-being of the patient, a multidis-
ciplinary and individualized supportive care is needed in
addition to the anticancer therapy. The benefits of various
supportive care interventions are already established, but
studies are still needed to clearly determine the best modal-
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